Virtual clinical research company seeks to bring clinical trials in-home, secures $31m

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/Ever)
(Image: iStock/Ever)

Related tags Clinical trial services Clinical trial Medicine

Science 37 has raised $31m in Series B financing to support its end-to-end decentralized clinical trial services and technology platform.

The Los Angeles-based company has developed a clinical trial operating model, the metasite™, which is based on its mobile research platform, the Network Oriented Research Assistant, or NORA™.

Science 37 CEO, Noah Craft, told us the technology enables participants and researchers to connect safely and securely from the patient's home.

Today’s clinical trial model is built around trial sites, each of which draws from a local geographic area. Up to 70 percent of potential patients live outside of these local areas​,” he said.

With pharmaceutical and medical device companies spending upwards of $50 billion annually on clinical trials and having up to 90 percent of these trials costing overruns and delays, there needed to be a change​.”

By offering end-to-end clinical trial services and removing geographical barriers, Craft said the company can make clinical research faster, ultimately accelerating the discovery of new therapeutics and devices.

The 'metasite'

Through Science 37’s model, physical sites are replaced with a single metasite™, enabling virtual trial specialists to access patients across a wider geographic area and larger demographic population.

This means that the patient is allowed to retain their existing doctor while benefiting from reduced travel time and access to quality healthcare via telemedicine or doctor home visits when appropriate​,” explained Craft.

Patients with rare diseases or those eligible for precision medicine can gain access to the same trials as those close to traditional sites, despite where they live​,” he added.

Craft explained that the company allows sponsors and researchers to streamline trial setup, accelerate recruiement, and improve patient retention. Enrollment, consent, and study execution are enabled by its NORA® platform.

Meanwhile, metasite study data is securely stored through the NORA® platform, so that data collection and site monitoring can take place in real-time and remotely​,” he added.

The recent investment will help the company grow operations and further develop its technology platform as well as expand into new therapeutic areas.

As part of the company's fundraising efforts, Science 37 also secured a strategic investment from Sanofi Genzyme BioVentures. In addition to financial backing, the company will provide Science 37 with technical and strategic guidance through interactions with their international development teams and affiliates.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us


View more